Trends in Adverse Event Reports of Dipeptidyl Peptidase-4 Inhibitor-Associated Pemphigoid in Japan

The number of reported DPP-4 inhibitor-associated pemphigoid events increased after the revised precautions of package inserts for DPP-4 inhibitors were released.

Authors

Institutions

Publication Details

Journal
Drugs - Real World Outcomes
Published
2026-01-12
DOI
https://doi.org/10.1007/s40801-025-00535-5
Citations
1
Primary Topic
Autoimmune Bullous Skin Diseases
Type
article
Field-Weighted Citation Impact
36.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trends in Adverse Event Reports of Dipeptidyl Peptidase-4 Inhibitor-Associated Pemphigoid in Japan

Koki Yamashita, Ataru Igarashi, Gen Terashima, Akina Takami et al.
1 citations
Drugs - Real World Outcomes
Autoimmune Bullous Skin Diseases
36.00
article

Trends in Adverse Event Reports of Dipeptidyl Peptidase-4 Inhibitor-Associated Pemphigoid in Japan

Koki Yamashita, Ataru Igarashi, Gen Terashima, Akina Takami, Takumi Tajima
article en
1 citations

Abstract

The number of reported DPP-4 inhibitor-associated pemphigoid events increased after the revised precautions of package inserts for DPP-4 inhibitors were released.

Drugs - Real World OutcomesVol. 13(1)
Department of Health (IE), The University of Tokyo (JP)
Openalex Percentile: Top 2%
Autoimmune Bullous Skin Diseases
36.00
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Trends in Adverse Event Reports of Dipeptidyl Peptidase-4 Inhibitor-Associated Pemphigoid in Japan — Koki Yamashita, Ataru Igarashi, et al. · Drugs - Real World Outcomes (2026) | TGRS Research Map | TGRS